Last month, the scientists behind Ozempic – hailed as a ‘miracle drug’ for weight-loss – were honoured by the Breakthrough ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Ozempic is on everyone's lips—sometimes even literally. This revolutionary diabetes drug has, unfortunately, become a social ...

Missing a dose of Ozempic may cause several side effects, including constipation, extreme hunger, diarrhea, and nausea, and increase the risk of diabetes complications. Missing an occasional dose ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and peripheral artery disease (PAD), potentially adding yet another ...